Suppr超能文献

相似文献

1
Memory-like natural killer cells for cancer immunotherapy.
Semin Hematol. 2020 Oct;57(4):185-193. doi: 10.1053/j.seminhematol.2020.11.003. Epub 2020 Nov 17.
2
NK cell-based cancer immunotherapy: from basic biology to clinical application.
Sci China Life Sci. 2015 Dec;58(12):1233-45. doi: 10.1007/s11427-015-4970-9. Epub 2015 Nov 20.
3
Human Cytokine-Induced Memory-Like Natural Killer Cells.
J Innate Immun. 2015;7(6):563-71. doi: 10.1159/000382019. Epub 2015 Apr 30.
5
Natural killer cell memory: challenges and opportunities for cancer immunotherapy.
Cancer Biol Ther. 2024 Dec 31;25(1):2376410. doi: 10.1080/15384047.2024.2376410. Epub 2024 Jul 10.
6
Cytokine-induced memory-like natural killer cells for cancer immunotherapy.
Stem Cell Res Ther. 2021 Dec 4;12(1):592. doi: 10.1186/s13287-021-02655-5.
7
Pharmacological targeting of natural killer cells for cancer immunotherapy.
Cancer Sci. 2020 Jun;111(6):1869-1875. doi: 10.1111/cas.14418. Epub 2020 May 5.
8
Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
Front Immunol. 2018 Sep 10;9:2041. doi: 10.3389/fimmu.2018.02041. eCollection 2018.
9
Natural killer cell biology: an update and future directions.
J Allergy Clin Immunol. 2013 Sep;132(3):536-544. doi: 10.1016/j.jaci.2013.07.006. Epub 2013 Jul 30.
10
Human NK cells: From development to effector functions.
Innate Immun. 2021 Apr;27(3):212-229. doi: 10.1177/17534259211001512. Epub 2021 Mar 24.

引用本文的文献

2
The landscape of CAR-engineered innate immune cells for cancer immunotherapy.
Nat Cancer. 2025 Jul 18. doi: 10.1038/s43018-025-01015-z.
3
Cytokine-induced memory-like NK cells combined with Tafasitamab demonstrate efficacy against B-cell acute lymphoblastic leukemia.
Immunother Adv. 2025 Jul 16;5(1):ltaf025. doi: 10.1093/immadv/ltaf025. eCollection 2025.
4
Immunotherapy for Platinum-Resistant Ovarian Cancer as a Glimmer of Hope.
Cells. 2025 Jun 29;14(13):995. doi: 10.3390/cells14130995.
5
Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinoma.
Mol Ther Oncol. 2025 May 26;33(2):201006. doi: 10.1016/j.omton.2025.201006. eCollection 2025 Jun 18.
7
Single cell atlas of canine natural killer cells identifies distinct circulating and tissue resident gene profiles.
Front Immunol. 2025 May 15;16:1571085. doi: 10.3389/fimmu.2025.1571085. eCollection 2025.
8
From induced pluripotent stem cell (iPSC) to universal immune cells: literature review of advances in a new generation of tumor therapies.
Transl Cancer Res. 2025 Apr 30;14(4):2495-2507. doi: 10.21037/tcr-24-1087. Epub 2025 Apr 15.
9
Autofluorescence lifetime imaging classifies human B and NK cell activation state.
Front Bioeng Biotechnol. 2025 Apr 4;13:1557021. doi: 10.3389/fbioe.2025.1557021. eCollection 2025.
10
Natural killer cell-based immunotherapy for cancer.
J Immunol. 2025 Apr 17. doi: 10.1093/jimmun/vkaf036.

本文引用的文献

1
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas.
Blood. 2020 Nov 12;136(20):2308-2318. doi: 10.1182/blood.2020006619.
2
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.
N Engl J Med. 2020 Feb 6;382(6):545-553. doi: 10.1056/NEJMoa1910607.
3
On the Way to Become a Natural Killer Cell.
Front Immunol. 2019 Aug 2;10:1812. doi: 10.3389/fimmu.2019.01812. eCollection 2019.
5
Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma.
Hepatol Int. 2019 Jan;13(1):75-83. doi: 10.1007/s12072-018-9909-3. Epub 2018 Nov 22.
6
ARID5B regulates metabolic programming in human adaptive NK cells.
J Exp Med. 2018 Sep 3;215(9):2379-2395. doi: 10.1084/jem.20172168. Epub 2018 Jul 30.
8
The Broad Spectrum of Human Natural Killer Cell Diversity.
Immunity. 2017 Nov 21;47(5):820-833. doi: 10.1016/j.immuni.2017.10.008.
9
CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.
J Clin Invest. 2017 Nov 1;127(11):4042-4058. doi: 10.1172/JCI90387. Epub 2017 Oct 3.
10
IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development .
Oncoimmunology. 2017 Jan 17;6(3):e1274478. doi: 10.1080/2162402X.2016.1274478. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验